Allostimulation-induced tumor cytotoxic cells: from mouse to man

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Experimental tumors can express cell surface antigens that cross-react with normal allogeneic tissues.
• This cross-reactivity, involving histocompatibility and differentiation antigens, can lead to immune responses against tumors.
• Previous studies show tumor rejection even without detectable cross-reacting antigens, indicating complex mechanisms.

Purpose of the Study:

• To review investigations on the generation of tumor-specific cytotoxic cells.
• To discuss the potential clinical applications of these cytotoxic cells in cancer therapy.

Main Methods:

• Review of existing experimental data on tumor rejection and cytotoxic cell generation.
• Analysis of studies involving immunization with allogeneic tissues and allostimulation of lymphocytes.
• Discussion of in vivo and in vitro experimental models in mice, rats, and humans.

Main Results:

• Immunization with allogeneic tissues bearing shared determinants can induce resistance to syngeneic tumors.
• Lymphocytes generated through allostimulation can exhibit cytotoxicity against syngeneic or autologous tumor cells.
• These processes result in the production of tumor-restricted cytotoxic cells, though underlying mechanisms vary.

Conclusions:

• The generation of tumor-restricted cytotoxic cells via allogeneic immunization or allostimulation is a significant finding.
• These cytotoxic cells hold potential for clinical utility in cancer treatment strategies.
• Further research is warranted to fully elucidate mechanisms and optimize therapeutic applications.